Clinical Trial Update: A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure [Phase 2]

View source ↗

Summary

This clinical trial update notes that the Phase 2 trial of alagebrium for improving exercise in diastolic heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure

Drugs mentioned

• Alagebrium (alagebrium)

Snippet

Sponsor: Cardiovascular Clinical Sciences Inc | Conditions: Diastolic Heart Failure | Phase 2 | Status: TERMINATED